Test. Better. Enhanced NIPT Reporting for Patients with Positive Results
About this webinar
Test. Better. With the marked increase in the use of cell-free DNA screening (cfDNA/NIPT) in clinical practice, many non-invasive prenatal test (NIPT) innovations were introduced as screening technology rapidly expanded over the past decade. But which NIPT innovations are likely to tangibly improve outcomes for your practice and patients? Which NIPT innovations improve test performance and bolster confidence knowing a screening result is reliable?
This webinar will present a new bioinformatics metric which will support counseling for patients with positive results. Using real-world case studies expert speakers will discuss enhancements to test reporting and how these improvements impact the positive predictive value associated with the result. This comprehensive, evidenced-based webinar will help you: Test. Better.
Who should attend
- Obstetricians and Gynecologists (OBGYN)
- Maternal Fetal Medicine Specialists (MFM)
- Genetic Counselors (GC)
- Nurses
- Medical Office Managers Working in the Field of Prenatal Care, Pregnancy, Labor and Delivery
What you will learn
- Examine how a new NIPT laboratory reporting metric influences positive predictive value
- Explore how these NIPT enhancements can support patient counseling
- Apply real world case studies to demonstrate how this new reporting metric can bring clarity to NIPT results
Featured Speakers
Thomas Westover, MD, FACOG
Thomas Westover MD FACOG is currently Chair of the New Jersey Section of the American College of Obstetrics & Gynecology, President of the NJ OBGYN Society, Co-Chair of the New Jersey Hospital Association Statewide Perinatal Safety Collaborative, Chief of Maternal Fetal Medicine at Capital Health System in Trenton, NJ and Associate Professor of MFM and OBGYN at Cooper Medical School Rowan University in Camden, NJ. He serves as a member of several NJ Dept of Health Committees and assists the NJ legislature on matters related to women’s health and family health.
Jill Rafalko, MS, CGC, LGC
Jill Rafalko is a board certified and licensed genetic counselor. Before joining Integrated Genetics, she worked as a prenatal genetic counselor for 8 years at New Jersey Perinatal Associates at Saint Barnabas Medical Center in Livingston, NJ. She completed her genetic counseling training at Mount Sinai School of Medicine.
Partner for this event
LabCorp
For more than 25 years, Integrated Genetics, a member of the LabCorp Specialty Testing Group, has been a pioneer in offering a true continuum of care in reproductive genetic testing from screening to diagnosis, and hereditary cancer testing services. Whether you are a patient or a healthcare provider, the broad reach of our specialty testing capabilities combined with over 5000 WH tests available from LabCorp means that we should be your choice of a laboratory partner for preconception, pregnancy and general women’s health.
Related webinars
More from LabCorp Clinical Trials.
Increasing Clinical Trial Diversity — Innovations to Overcome Barriers to Trial Participation
Recipes for Trial Acceleration & Improved Patient Engagement Through Comprehensive, Integrated Mobile Clinical Services
Circulating Tumor Cells as a Biomarker Approach in Oncology
Companion Diagnostics (CDx): Accelerating the Path to Commercialization
Advancements in Endocrine Testing – Case Studies and Solutions for Clinical Trials
